Pusalkar, Sandeepraj et al
"Biotransformation Pathways and Metabolite Profiles of Oral [14C]-Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors." Drug Metabolism and Disposition
(2020):
dmd.119.087338.
Web. 28 Sept2023.
